
It starts with patients.
Cell, tissue, and organ replacements are redefining treatment experiences for degenerative diseases.
Our Therapies
Personalized replacements address some of the most challenging diseases.
Congenital Heart DiseaseKidney DiseaseDiabetesAlzheimer’sObesityParkinson’sUrinary Incontinence Spinal Cord InjuryMacular DegenerationMuscular DystrophyLung DiseaseInfertility1.0
Deep Learning

Our AI algorithms consistently deliver reproducible, scalable biomanufacturing, far exceeding traditional manual methods.
1.0
Cellinoverse

A digital environment simulating life-like biomanufacturing behavior in silico
2.0
Laser cell management
Laser-generated bubbles precisely remove unwanted cells to control cell density with unprecedented precision.
2.0
Optical Bioprocess

A closed-loop, image-guided optical bioprocess delivers consistent, reproducible results over time by minimizing human variability.
3.0
Tech Stack



3.0
Tech Stack

The Nebula™ platform compresses traditional infrastructure into modular, cassette-based systems, enabling scalable deployment. These systems can power large-scale distributed foundries or be localized in hospitals, dramatically expanding patient access to advanced treatments.
Nebula powers the scalable production of biologically younger, living medicines—transformative, one-time treatments for chronic degenerative conditions. By leveraging self-sourced therapies, it eliminates the need for immunosuppression, dramatically expanding patient access and treatment potential.
Our Languages
























